|
Aug 6
|
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
|
|
Jul 30
|
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
|
|
Jul 24
|
We're Not Very Worried About Relay Therapeutics' (NASDAQ:RLAY) Cash Burn Rate
|
|
Jun 6
|
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
|
|
Jun 5
|
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
|
|
May 13
|
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
|
|
May 4
|
Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
|
May 2
|
Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
|
|
May 2
|
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
|
|
Apr 25
|
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
|
|
Apr 11
|
Relay Therapeutics to Participate in Upcoming Investor Conferences
|
|
Mar 17
|
11 Oversold Biotech Stocks To Buy Right Now
|
|
Mar 15
|
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
|
|
Mar 13
|
Does Relay Therapeutics, Inc. (RLAY) Have the Potential to Rally 146.52% as Wall Street Analysts Expect?
|
|
Feb 26
|
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
|
|
Feb 26
|
Wall Street Analysts See a 131.6% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High?
|
|
Feb 24
|
Relay Therapeutics Full Year 2023 Earnings: Beats Expectations
|
|
Feb 15
|
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
|
|
Feb 15
|
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
|